VSTM:NASDAQ
Verastem Inc
$7.32
arrow_downward
-3.94%(-0.30) 1D
$7.43
arrow_upward
+1.50% (+0.11)bedtimeAfter hours
Closed: Sep 11, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VSTM...
Open
$7.70
High
$7.79
Low
$7.32
Mkt. cap
662.92M
Avg. vol.
2.12M
Volume
1.91M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.32
Shares outstanding
90.56M
No. of employees
102
Open
$7.70
High
$7.79
Low
$7.32
Mkt. cap
662.92M
Avg. vol.
2.12M
Volume
1.91M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.32
Shares outstanding
90.56M
No. of employees
102
News stories
From web sources and news partners
GuruFocus
·
1 day ago
VSTM Reiterated by HC Wainwright & Co. -- Price Target Maintained at $18
Investing.com
·
2 days ago
Verastem at Cantor conference: dual-track growth, big bets
Profile
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
About Verastem Inc
CEOBrian Stuglik
Employees102
Founded2010
HeadquartersNeedham, Massachusetts, United States
SectorBiotechnology
Websiteverastem.com